Product Reports Resources Pricing Login Book a demo

Physera

Health · San Francisco, United States · Founded 2015

Physera is modernizing musculoskeletal care through direct access to top providers and personalized treatment MoreLess

Physera, founded in 2015 by Dan Rubinstein and Cameron Marlow, developed a digital platform for delivering musculoskeletal (MSK) care. The company's primary offering was a mobile application that connected patients with licensed physical therapists for virtual consultations, diagnosis, and personalized exercise programs. This telehealth service was designed to address the high costs and accessibility issues associated with traditional physical therapy, targeting a U.S. market where annual spending on MSK conditions exceeds $200 billion.

The founders' backgrounds were instrumental in shaping the company's data-driven approach. CEO Dan Rubinstein, who holds a Ph.D. in Statistics from Stanford, previously held product leadership roles at Facebook, Google, and Palantir, and was an Entrepreneur in Residence at Khosla Ventures. His interest in healthcare was fueled by a desire to apply the predictive and closed-loop modeling used by tech giants to improve patient outcomes. CTO Cameron Marlow, who also worked at Facebook as Head of Data Science and holds a Ph.D. from MIT Media Lab, brought deep expertise in data science and technology. Together, they aimed to make evidence-based care more convenient and effective.

Physera’s business model served employers, health plans, and direct-to-consumer channels. For employers, the value proposition was reducing healthcare spending by preempting unnecessary surgeries, imaging, and opioid prescriptions. The platform's features included video access to physical therapists, in-app animations, voice prompts for exercises, and progress monitoring to improve patient adherence. A significant milestone for Physera was its acquisition by Omada Health in May 2020 for a reported $30 million. The acquisition integrated Physera's MSK solution into Omada's broader digital care suite, which already addressed chronic conditions like diabetes and hypertension, creating a more comprehensive virtual care offering.

Keywords: Physera, musculoskeletal care, digital physical therapy, telehealth, virtual care, Omada Health, Dan Rubinstein, Cameron Marlow, health technology, remote patient monitoring, digital health, exercise therapy, chronic pain management, virtual physical therapy platform, MSK solutions, telehealth physical therapy, corporate wellness, health plan solutions, direct-to-consumer healthcare

Talent graph

Physera's talent

Book a demo to see the people
Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

9 investors on Physera's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 6 investors entered at this stage
Lux Capital
Innovation Endeavors
Expa
Slow Ventures
iD Ventures America
Bradley Horowitz
Series A 3 investors entered at this stage
J-Ventures
Blue Venture Fund
BlueCross BlueShield Venture Partners

Global footprint

Where Physera has talent and traffic

Workforce by country
2 countries with
team presence
🇺🇸 United States90%
🇮🇳 India10%
2 countries shown

Market sentiment

What the market is saying about Physera

An AI-synthesized read of the highest-engagement posts about Physera on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Physera on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.